Lucia Saldana
Physician Assistant · Mission, TXNPI 1316071335
Payments from drug & device makers
Across 328 payments — averaging $19.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$800
- Lilly USA, LLC$711
- Astellas Pharma US Inc$556
- Amgen$364
- GSK$319
- plus $2K from 30 others
What the payments were for
- Food & beverage$5,97095%
- Education$2885%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 75 | $1,297 |
| Novo Nordisk | 50 | $800 |
| Lilly USA, LLC | 43 | $711 |
| Astellas Pharma US Inc | 20 | $556 |
| Amgen | 19 | $364 |
| GSK | 15 | $319 |
| Boehringer Ingelheim | 11 | $273 |
| Pfizer | 13 | $261 |
| Abbott | 6 | $199 |
| AstraZeneca | 11 | $184 |
| Sumitomo Pharma America, Inc. | 7 | $168 |
| Johnson & Johnson | 6 | $133 |
| Otsuka America Pharmaceutical, Inc. | 5 | $120 |
| Exact Sciences | 6 | $111 |
| Dexcom, Inc. | 5 | $97 |
| Phathom Pharmaceuticals, Inc. | 4 | $81 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $77 |
| Novartis | 4 | $68 |
| Bayer | 3 | $66 |
| Ardelyx, Inc. | 2 | $47 |
| Kowa Pharmaceuticals America, Inc. | 2 | $36 |
| Lundbeck LLC | 1 | $27 |
| Averitas Pharma Inc. | 1 | $27 |
| Madrigal Pharmaceuticals | 1 | $23 |
| Phadia US Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Genentech USA, Inc. | 2 | $18 |
| Acclarent, Inc | 1 | $17 |
| Merck | 1 | $17 |
| Philips North America LLC | 1 | $17 |
| Mylan Specialty L.p. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Radius Health, Inc. | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FREESTYLE LIBRE 3$128
- UBRELVY$124
How this compares
$6,258 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 112 | $164,672 |
| MounjaroTirzepatide | 54 | $89,347 |
| JardianceEmpagliflozin | 57 | $70,970 |
| JanuviaSitagliptin Phosphate | 47 | $60,604 |
| JanumetSitagliptin Phos/Metformin Hcl | 25 | $31,794 |
| LinzessLinaclotide | 43 | $27,526 |
| FarxigaDapagliflozin Propanediol | 24 | $27,515 |
| TrulicityDulaglutide | 15 | $26,661 |
| ProliaDenosumab | 15 | $24,381 |
| EliquisApixaban | 20 | $23,943 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 29 | $23,415 |
| XareltoRivaroxaban | 22 | $23,039 |
| MyrbetriqMirabegron | 19 | $17,055 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $8,768 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $3,380 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $800 | $164,672112 claims |
| Lilly USA, LLCMounjaro, Trulicity | $711 | $116,00869 claims |
| MerckJanuvia, Janumet | $17 | $92,39872 claims |
| Boehringer IngelheimJardiance | $273 | $70,97057 claims |
| AbbVieLinzess | $1,297 | $27,52643 claims |
| AstraZenecaFarxiga | $184 | $27,51524 claims |
| AmgenProlia | $364 | $24,38115 claims |
| PfizerEliquis | $261 | $23,94320 claims |
| GSKTrelegy Ellipta | $319 | $23,41529 claims |
| Johnson & JohnsonXarelto | $133 | $23,03922 claims |
| Astellas Pharma US IncMyrbetriq | $556 | $17,05519 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in Mission
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Anthony DerenciusSan Antonio$507K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.